GRAY SUSANNAH 4
4 · Theravance Biopharma, Inc. · Filed Feb 28, 2023
Insider Transaction Report
Form 4
GRAY SUSANNAH
Director
Transactions
- Award
Ordinary Shares
2023-02-26+10,131→ 10,131 total - Award
Ordinary Shares
2023-02-26+1,688→ 11,819 total - Award
Share Option (Right to Buy)
2023-02-26+28,000→ 28,000 totalExercise: $9.87Exp: 2033-02-25→ Ordinary Shares (28,000 underlying) - Award
Share Option (Right to Buy)
2023-02-26+4,666→ 4,666 totalExercise: $9.87Exp: 2033-02-25→ Ordinary Shares (4,666 underlying)
Footnotes (2)
- [F1]The option vests monthly over 24 months of service from the date of grant.
- [F2]This option shall vest monthly over two months of service from the date of grant and will vest in full upon earlier of the two-month anniversary of Susannah Gray's appointment to the Board or the date of Company's 2023 annual meeting of Shareholders.